Leonflax Flax Seed Fat Reducer
En vente sur le marché américain (selon le DSLD)
LEONFLAX, food supplement from the US market
Leonflax Flax Seed Fat Reducer (LEONFLAX), a food supplement au code-barres 899053001009, is described by its US market label. If sold in France, it would be subject to 4 points of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
If this product were sold in France
- Dose déclarée au-delà d'une limite
Potassium: up to 97.8 mg a day according to the label (at most 1 serving a day), above the maximum dose of 80 mg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
- Conditions légales
Linum usitatissimum L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Conditions légales
Senna alexandrina Mill.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- LEONFLAX
- Barcode
- 899053001009
- Form
- Powder
- One serving
- 15 g
- Servings
- up to 1 serving per day
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Calories | Other | 57.5 Calorie(s) |
| Calories from Fat | Other | 31.39 Calorie(s) |
| Total Fat | Fat | 3.75 Gram(s) |
| Saturated Fat | Fat | 0.3 Gram(s) |
| Carbohydrates | Carbohydrate | 5.85 Gram(s) |
| Fiber | Fibre | 4,000 mg |
| Sodium | Mineral | 2.74 mg |
| Potassium | Mineral | 97.8 mg |
| Protein | Protein | 2,100 mg |
| Proprietary Blend | Blend | 15 Gram(s) |
| Canadian Flax (Linum usitatissimum) | Plant | not stated |
| Wheat Bran | Fibre | not stated |
| Maca (Lepidium meyenii) | Plant | not stated |
| Oat Bran | Fibre | not stated |
| Psyllium | Fibre | not stated |
| Nopal/Cactus (Opuntia ficus-indica) | Plant | not stated |
| Noni (Morinda citrifolia) | Plant | not stated |
| Grapefruit (Citrus paradisi) | Plant | not stated |
| Apple | Plant | not stated |
| Pineapple (Ananas comosus) | Plant | not stated |
| Orange (Citrus sinensis) | Plant | not stated |
| Papaya (Carica papaya) | Plant | not stated |
| Senna (Senna alexandrina) | Plant | not stated |
| Alpha-Linolenic Acid | Fatty acid | 1,950 mg |
| Linoleic Acid | Fatty acid | 570 mg |
| Oleic Acid | Fatty acid | 285 mg |
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Leonflax Flax Seed Fat Reducer
Entered into DSLD on 24 September 2019. En vente sur le marché américain (selon le DSLD).- Active ingredient removed : Alpha-Linolenic Acid (1,950 mg)
- Active ingredient removed : Calories (57.5 Calorie(s))
- Active ingredient removed : Calories from Fat (31.39 Calorie(s))
- Active ingredient removed : Carbohydrates (5.85 Gram(s))
- Active ingredient removed : Fiber (4,000 mg)
- Active ingredient removed : Linoleic Acid (570 mg)
- Active ingredient removed : Oleic Acid (285 mg)
- Active ingredient removed : Potassium (97.8 mg)
- Active ingredient removed : Protein (2,100 mg)
- Active ingredient removed : Saturated Fat (0.3 Gram(s))
- Active ingredient removed : Sodium (2.74 mg)
- Active ingredient removed : Total Fat (3.75 Gram(s))
- Same quantity, different name: Nopal in this version; Nopal/Cactus on the displayed label (quantity not stated)
- Different unit, without conversion : Proprietary Blend: 1,000 mg in this version; 15 Gram(s) on the displayed label
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Canadian Flax
Read the warning, when it applies and the studies cited
FLAXSEED - LINUM USITATISSIMUM
Route of administration: Oral
Cautions and warnings
Applies to products providing 5 g or more of flaxseed per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician immediately if you experience chest pain, vomiting, or difficulty swallowing or breathing after taking this product (EMA 2015).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes or a lazy bowel (EMA 2015; ESCOP 2003).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Laxative; Promotion of bowel movement; Constipation.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (Pray 2006; Repchinsky 2002).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Applies to products providing 5 g or more of flaxseed per day.
Do not use if you have difficulty swallowing (EMA 2015; ESCOP 2003).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Do not use if you have fever or any undiagnosed gastrointestinal trouble (EMA 2015; Gardner and McGuffin 2013; Brinker 2010; ESCOP 2003).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Condition of application: All products.
Stop use if hypersensitivity/allergy occurs (EMA 2015; León et al. 2003).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Maca
Read the warning, when it applies and the studies cited
Maca - Lepidium Meyenii
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Applies to products providing 0.6 g or more dried root/hypocotyl, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a blood pressure condition (Valentova et al. 2008).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Gonzales and Gonzales-Castaneda 2009; Dording et al. 2008).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Healthy mood balance; Sexual health.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have psychological disorders such as anxiety or depression (Brotto 2010; Gonzales and Gonzales-Castaneda 2009; Dording et al. 2008).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Senna
Read the warning, when it applies and the studies cited
SENNA - SENNA ALEXANDRINA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a kidney disorder or a lazy bowel (EMA 2018a,b; Brinker 2010; Blumenthal et al. 2000; WHO 1999).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking heart medications, corticosteroids, diuretics, or other health products that may contribute to electrolyte imbalance (EMA 2018a,b; Brinker 2010; Blumenthal et al. 2000; WHO 1999).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Do not use if you are pregnant or breastfeeding (EMA 2018a,b; Brinker 2010; Blumenthal et al. 2000).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Do not use if you have inflammatory bowel disease, fever or any undiagnosed gastrointestinal trouble (EMA 2018a,b; Gardner and McGuffin 2013; Brinker 2010; WHO 1999).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Stop use if hypersensitivity/allergy or diarrhoea occurs (EMA 2018a,b; Blumenthal et al. 2000; WHO 1999).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : LEONFLAX
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.